0
0
0
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
3/9/2024, 8:15 AM
Summary of Bill HR 1393
Bill 118 hr 1393 aims to make changes to the Controlled Substances Act in order to better define what constitutes currently accepted medical use with severe restrictions. The bill seeks to clarify the regulations surrounding the use of controlled substances for medical purposes, particularly in cases where there are strict limitations on their use.
The proposed legislation would provide a more precise definition of what qualifies as currently accepted medical use with severe restrictions, ensuring that patients who require these substances for legitimate medical reasons are able to access them while also preventing misuse and abuse. The bill also includes provisions for monitoring and regulating the distribution of these substances to ensure they are being used appropriately.
Overall, Bill 118 hr 1393 is aimed at striking a balance between providing access to necessary medications for patients with severe medical conditions while also implementing safeguards to prevent misuse and abuse of controlled substances. It is an important piece of legislation that seeks to address the complexities of regulating controlled substances for medical use in a responsible and effective manner.
The proposed legislation would provide a more precise definition of what qualifies as currently accepted medical use with severe restrictions, ensuring that patients who require these substances for legitimate medical reasons are able to access them while also preventing misuse and abuse. The bill also includes provisions for monitoring and regulating the distribution of these substances to ensure they are being used appropriately.
Overall, Bill 118 hr 1393 is aimed at striking a balance between providing access to necessary medications for patients with severe medical conditions while also implementing safeguards to prevent misuse and abuse of controlled substances. It is an important piece of legislation that seeks to address the complexities of regulating controlled substances for medical use in a responsible and effective manner.
Congressional Summary of HR 1393
This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)
Read the Full Bill
Current Status of Bill HR 1393
Bill HR 1393 is currently in the status of Bill Introduced since March 7, 2023. Bill HR 1393 was introduced during Congress 118 and was introduced to the House on March 7, 2023. Bill HR 1393's most recent activity was Referred to the Subcommittee on Health. as of March 17, 2023
Bipartisan Support of Bill HR 1393
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
28Democrat Cosponsors
14Republican Cosponsors
14Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1393
Primary Policy Focus
Crime and Law EnforcementAlternate Title(s) of Bill HR 1393
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Comments
Sponsors and Cosponsors of HR 1393
Latest Bills
TRAPS Act
Bill HR 4936September 18, 2026
Apples to Apples Comparison Act of 2025
Bill HR 4093September 18, 2026
American Lending Fairness Act of 2026
Bill HR 7866September 18, 2026
Civil Investigative Demand Reform Act of 2025
Bill HR 1653September 18, 2026
American Reserve Modernization Act of 2026
Bill HR 8957September 18, 2026
Preventive Health Savings Act
Bill HR 4464September 18, 2026
PEARL Act
Bill HR 9327September 18, 2026
Medically Tailored Home-Delivered Meals Program Pilot Act
Bill HR 5439September 18, 2026
To designate the facility of the United States Postal Service located at 117 West Lovett Street in Charlotte, Michigan, as the "Francis C. Flaherty Post Office Building".
Bill HR 9570September 18, 2026
To designate the facility of the United States Postal Service located at 1019 Avenue H in Fort Madison, Iowa, as the "Martin L. Graber Post Office".
Bill HR 4707September 18, 2026
A bill to amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.
Bill S 689March 13, 2024





